| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Respiratory Disease Service, Hospital Universitario 12 de Octubre, Madrid, Spain
Study objective: Identification of predictive factors for the development of residual pleural thickening (RPT).
Design: Retrospective study.
Location: A 1,500-bed tertiary hospital.
Patients: Patients with pleural tuberculosis diagnosed between December 1991 and February 1995 in our Respiratory Disease Service.
Interventions: The clinical and radiologic characteristics, and measurements of microbiological and biochemical parameters and markers in pleural fluid were studied. RPT was defined in a posteroanterior chest radiograph as a pleural space of >2 mm measured in the lower lateral chest at the level of an imaginary line intersecting the diaphragmatic dome.
Measurements and results: In 56 patients studied, 11 (19.6%) had RPT 10 mm and 24 (42.8%) had RPT >2 mm. The pleural fluid of patients with RPT 10 mm had a significantly lower glucose concentration and pH and higher lysozyme and tumor necrosis factor-
levels than the other patients. The pleural fluid of patients with RPT >2 mm showed no significant differences.
Conclusions: The development of RPT 10 mm was related to higher concentrations of lysozyme and tumor necrosis factor- and lower glucose concentration and pH in pleural fluid compared with development of lower measurements of RPT.
Key Words: lysozyme • pleural inflammation • pleural thickening • pleural tuberculosis • tumor necrosis factor-
Submitted on December 13, 1996
Accepted on May 17, 1997
This article has been cited by other articles:
|
|
 |
|
  D.-H. Han, J.-W. Song, H.-S. Chung, and J.-H. Lee Resolution of Residual Pleural Disease According to Time Course in Tuberculous Pleurisy During and After the Termination of Antituberculosis Medication Chest, November 1, 2005; 128(5): 3240 - 3245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Chung, C.-H. Chen, J.-R. Sheu, Y.-C. Chen, and S.-C. Chang Proinflammatory Cytokines, Transforming Growth Factor-{beta}1, and Fibrinolytic Enzymes in Loculated and Free-Flowing Pleural Exudates Chest, August 1, 2005; 128(2): 690 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jimenez Castro, G. Diaz, E. Perez-Rodriguez, and R.W. Light Prognostic features of residual pleural thickening in parapneumonic pleural effusions Eur. Respir. J., June 1, 2003; 21(6): 952 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Candela, J. Andujar, L. Hernandez, C. Martin, E. Barroso, J. M. Arriero, and S. Romero Functional Sequelae of Tuberculous Pleurisy in Patients Correctly Treated Chest, June 1, 2003; 123(6): 1996 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Chung, Y.-C. Chen, and S.-C. Chang Effect of Repeated Thoracenteses on Fluid Characteristics, Cytokines, and Fibrinolytic Activity in Malignant Pleural Effusion Chest, April 1, 2003; 123(4): 1188 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y-F Lai, T-Y Chao, Y-H Wang, and A-S Lin Pigtail drainage in the treatment of tuberculous pleural effusions: a randomised study Thorax, February 1, 2003; 58(2): 149 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Hua, L.-C. Chang, Y.-C. Chen, and S.-C. Chang Proinflammatory Cytokines and Fibrinolytic Enzymes in Tuberculous and Malignant Pleural Effusions Chest, November 1, 1999; 116(5): 1292 - 1296. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
